Search
Fondaparinux
go.drugbank.com/drugs/DB00569ApprovedInvestigationalFondaparinux (Arixtra) is a synthetic anticoagulant agent consisting of five monomeric sugar units and a O-methyl group at the reducing end of the molecule. … Fondaparinux may be used: to prevent venous thromboembolism in patients who have undergone orthopedic surgery of the lower limbs (e.g. hip fracture, hip replacement and knee surgery); to prevent VTE in
Products: ENJ. COZELTI ICEREN KULLANIMA HAZIR SIRINGA, 2 ADET, ENJ. COZELTI ICEREN KULLANIMA HAZIR SIRINGA, 10 ADETBisacodyl
go.drugbank.com/drugs/DB09020ApprovedInvestigational[A233290,A233300,A207700] Bisacodyl was patented on 25 September 1956[L33045] but has been used as a laxative since 1952.[A233300]
Products: Soflax EX 5, Soflax EX 10Quinapril
go.drugbank.com/drugs/DB00881ApprovedInvestigational[L8420,L8423] ACE inhibitors are commonly used as a first line therapy in the treatment of hypertension, along with thiazide diuretics or beta blockers. … [A184844] Quinapril was granted FDA approval on 19 November 1991.[L8420] A combination tablet with [hydrochlorothiazide] was also approved on 28 December 1999.[L8423]
Mixtures: QUINAPRIL IDROCLOROTIAZIDE EG, QUINAPRIL IDROCLOROTIAZIDE EGCategories: Agents Acting on the Renin-Angiotensin SystemIsosorbide mononitrate
go.drugbank.com/drugs/DB01020ApprovedInvestigationalIsosorbide mononitrate is an organic nitrate with vasodilating properties. … [L11698, L11743] Isosorbide mononitrate is an active metabolite of [isosorbide dinitrate].
Synonyms: IS 5-MN, IS-5-MNCategories: Vasodilators Used in Cardiac DiseasesPheniramine
go.drugbank.com/drugs/DB01620Approved[A181628] It is used in some over-the-counter allergy as well as cold & flu products in combination with other drugs. … Pheniramine is a first-generation antihistamine in the alkylamine class, similar to [brompheniramine] and [chlorpheniramine].
Mixtures: OCTILIA ALLERGIA E INFIAMMAZIONE, OCTILIA ALLERGIA E INFIAMMAZIONEProducts: FENAMED 45,5 MG/2 ML IM/IV ENJ. COZ. ICEREN 50 AMPUL, FENAMED 45,5 MG/2 ML IM/IV ENJ. COZ. ICEREN AMPUL, 5 ADETSigma receptor
go.drugbank.com/bio_entities/BE0004897TargetHumansComponent of a progesterone-binding protein complex (PubMed:28396637). Binds progesterone (PubMed:25675345). Has many reported cellular functions (heme homeostasis, interaction with CYPs).
Polypeptides: Membrane-associated progesterone receptor component 1Methoxy polyethylene glycol-epoetin beta
go.drugbank.com/drugs/DB09107ApprovedInvestigationalMethoxy polyethylene glycol-epoetin beta is a chemically synthesised Erythropoiesis Stimulating Agent (ESA) with a longer half-life than erythropoietin. ESA is used to increase synthesis of red blood cells to treat chronic kidney disease...
Categories: Compounds used in a research, industrial, or household settingProducts: MIRCERA ROCHE 30 MCG/0,3 ML SC/IV ENJ. ICIN KULLANIMA HAZIR SIRINGA, MIRCERA ROCHE 50 MCG/0,3 ML SC/IV ENJ. ICIN KULLANIMA HAZIR SIRINGABudesonide
go.drugbank.com/drugs/DB01222ApprovedInvestigational[A188529,A188532] Budesonide was granted FDA approval on 14 February 1994.[L10598] It is also available in a combination product with [formoterol].[L10619]
Mixtures: BUDESONIDE E FORMOTEROLO SANDOZ, BUDESONIDE E FORMOTEROLO SANDOZProducts: BUDESONIDA 50 MCG INHALADOR EN AEROSOL, BUDESONIDA 100 MCG SUSPENSION ACUOSA NASAL EN AEROSOL.Urokinase
go.drugbank.com/drugs/DB00013ApprovedInvestigationalWithdrawnUrokinase is an endogenous peptide that is cleaved in the presence of plasmin between lysine 158 and isoleucine 159 to yield active urokinase. … [A191943] Urokinase was granted FDA approval on 16 January 1978.[L12138]
Products: UROCHINASI EGThiotepa
go.drugbank.com/drugs/DB04572ApprovedInvestigationalIt is a stable derivative of N,N',N''- triethylenephosphoramide (TEPA). It is mostly used to treat breast cancer, ovarian cancer and bladder cancer. … N,N'N'-triethylenethiophosphoramide (ThioTEPA) is a cancer chemotherapeutic member of the alkylating agent group, now in use for over 50 years.
Synonyms: N,N′,N′′-tri-1,2-ethanediyl-, Phosphorothioic triamide, N,N′,N′′-tri-1,2-ethanediyl-Products: Thiotepa Fresenius Kabi 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung, Thiotepa Fresenius Kabi 15 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung